Belite Bio, Inc (NASDAQ:BLTE) appears in 17 institutional 13F filings for the quarter ending June 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | 31 Mar, 2026 | 3,057,412 | 29,708 | 0.98% | $456,104,722.00 |
| Paradigm Biocapital Advisors LP | 31 Mar, 2026 | 1,114,784 | 1,114,784 | 0.00% | $177,741,161.00 |
| UBS Group AG | 31 Mar, 2026 | 768,359 | 639,607 | 496.77% | $122,507,159.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 715,332 | 0 | 0.00% | $114,052,534.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 570,088 | 11,206 | 2.01% | $90,894,831.00 |
| Holocene Advisors, LP | 31 Mar, 2026 | 494,495 | 410,428 | 488.22% | $78,842,283.00 |
| EVENTIDE ASSET MANAGEMENT, LLC | 31 Mar, 2026 | 357,650 | -25,441 | -6.64% | $57,023,716.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Mar, 2026 | 304,013 | 70,200 | 30.02% | $48,471,833.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 281,805 | 281,805 | 0.00% | $44,931.00 |
| Morgan Stanley | 31 Mar, 2026 | 201,409 | 173,396 | 618.98% | $32,112,649.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 151,979 | -262,260 | -63.31% | $24,231,532.00 |
| Patient Square Capital LP | 31 Mar, 2026 | 116,684 | 116,684 | 0.00% | $18,604,097.00 |
| Duquesne Family Office LLC | 31 Mar, 2026 | 106,100 | 106,100 | 0.00% | $16,917.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 105,509 | 16,311 | 18.29% | $16,822,355.00 |
| MPM BioImpact LLC | 31 Mar, 2026 | 88,045 | 285 | 0.32% | $14,037,895.00 |
| Affinity Asset Advisors, LLC | 31 Mar, 2026 | 65,000 | 45,000 | 225.00% | $10,363,600.00 |
| FRED ALGER MANAGEMENT, LLC | 31 Mar, 2026 | 62,574 | -16,820 | -21.19% | $9,976,799.00 |
| PFM Health Sciences, LP | 31 Mar, 2026 | 59,432 | 39,609 | 199.81% | $9,475,838.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 52,000 | 52,000 | 0.00% | $8,290,880.00 |
| EverSource Wealth Advisors, LLC | 31 Mar, 2026 | 43,249 | 41,651 | 2,606.45% | $2,092,240.00 |